Community/Retail

Training and knowledge about appropriate communication with individuals of diverse backgrounds improves adherence, outcomes.

Routine depression screening in the primary care setting lowered screening disparities and increased recognition of symptoms for groups at risk of undertreatment, including racial and ethnic minority individuals and patients of older age.

With the help of pharmacists and a team of health care providers, a better quality of life is possible for patients with Parkinson disease.

A new study suggests that work and private life mental stressors are disrupting sleep in older employees, potentially wreaking havoc on health.

Researchers find that the risk of developing dementia increased by 35% in patients with atrial cardiopathy.

Latanoprost (Xalatan) Sterile Ophthalmic Solution is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Wellblends Immune & Respiratory is a 3-in-1 blend designed with ingredients to provide advanced immune support.

In a recent survey, researchers identified rising costs, socioeconomic inequity, and drug trends as major concerns for large employers.

Analysis is based on previously reported data collected in March and April 2022, with the FDA granting emergency use authorization for individuals aged 6 months to 4 years on June 17.

Pharmacists, being one of the most accessible health care professionals, are critical pieces of the opioid tapering program puzzle.

The vaccine candidate is composed of 2 preF proteins selected to optimize protection against the RSV A and B strains.

During the surge caused by the Delta variant, a third dose of the Pfizer-BioNTech COVID-19 vaccine reduced infections and COVID-19-related hospitalizations and deaths among patients in long term care facilities.

With proper knowledge, they can complete self-examinations and be adherent to clinical exams.

Protazen is intended to help with mental and mood enhancement.

Early detection of chronic kidney disease is vital to preventing comorbid conditions.

The phase 2 study will evaluate the efficacy and safety of 2 different doses of MK-2060 in patients with ESRD receiving hemodialysis via an arteriovenous graft.

Analysis includes nearly 43 million individuals aged 13 year and older who received at least 1 dose in England between December 1, 2020, and December 15, 2021.

George Rafferty and Jason Dinger of AmerisourceBergen discuss the investment interests of the venture capital fund AB Health Ventures within the retail pharmacy space.

Survey data indicates that people experiencing homelessness had a lower annual incidence of COVID-19 despite having a higher burden of infectious diseases, suggesting opportunities for better integration of homelessness status in infectious disease reporting.

A systematic review of literature found that family history of psychiatric disorders is a risk factor associated with postpartum depression, adding to a contradictory body of research.

This month's generic product new features vilazadone tablets, leuprolide acetate injection, and oxcarbazepine tablets.

Evaluating nonprescription medications, including dietary supplements, can prevent adverse effects.

Results also show that no association with an increased frequency of myocarditis, venous thromboembolism, or worsening HF in these individuals.

High-level ethical decision making considers various ethical components and all stakeholders.

The mRNA-1273.222 vaccine candidate targets both the original SARS-CoV-2 strain in addition to the BA.4/BA.5 subvariants of the Omicron strain.

Danish analysis looks at the relationship between the therapy and cardiovascular adverse effects, particularly arrhythmias.

Auvelity is a combination of dextromethorphan and bupropion indicated for the treatment of major depressive disorder in adults.

Acetaminophen helps to reduce fevers and treat headaches, pains, and menstrual cramps.

The companies are prepared to deliver doses of the Omicron-adapted bivalent vaccine for September, pending authorization.

Less than half of fully vaccinated individuals in the United States have received a COVID-19 booster dose, with lower uptake rates among individuals with less education, lower socioeconomic status, and current enrollment in Medicaid.